Skip to content
‹ Back to IndustriesHealthcare

Extending Performance Requires A Collaboration Between Different Disciplines

Joel Totoro’s love for professional sports and health has teed him up for a successful career as Director of Sports Science at Thorne. Totoro noticed that the development of a holistic approach has helped extend careers. Teams now include full-time dieticians, psychologists, physical therapists, and the primary care team. “Using health and wellness can be…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Joel Totoro’s love for professional sports and health has teed him up for a successful career as Director of Sports Science at Thorne. Totoro noticed that the development of a holistic approach has helped extend careers. Teams now include full-time dieticians, psychologists, physical therapists, and the primary care team.

“Using health and wellness can be an enhancer in the game,” Totoro recognizes that extended careers are attributed to “the collaboration between different disciplines, nutrition and metabolic, strength coaches, psychologist, taking care of it [wellbeing] from all aspects.” Health is an interconnected system. We’re shifting and becoming more focused on preventative care, and understandably, Totoro says, “is what healthcare should be.”

Thorne is leading the way in quality and effective supplements. Thorne’s supplements are strictly made with rigorous testing and the best ingredients to ensure high quality. Totoro understands that Thorne is in the “service industry, at the end of the day. We want you to be as healthy as you can be for as long as you can be.” If the product isn’t improving the overall quality of life, it’s not doing its job. “[Thorne is] altruistically driven, and that isn’t [a factor] in other supplement companies,” explains Totoro.

In an industry with a bad rap, supplements tend to be a money-driven business. Thorne is setting the bar high in terms of quality control. Many of Thorne’s supplements are backed by NSF Certified for Sport. They provide peace of mind to professional athletes whose livelihood depends on clean testing before a performance. If a supplement had a filler, which may not be dangerous to an individual, but is considered illegal in a sport, the athlete’s career could be on the line. Thorne’s high standards honor that athletes’ careers depend on reliable products.

Thorne offers personalized, scientific testing and solutions so that individuals can create custom supplement regimens. Totoro explains that Thorne empowers its customers with “individual control and understanding.”

While Thorne’s standards are a huge differentiator, Totoro explains, “what’s really exciting is the fact that we have partners in the medical space.” Recently, Thorne developed a supplement for brain health after a concussion with The Mayo Clinic. The supplement gives the brain the nutrients to support cell growth, ultimately benefitting memory and focus.

From professional athletes to laypeople, Thorne provides the tools for individuals to improve and maintain their health. After all, as Totoro says, “you are the CEO of you,” and you have to “do what’s best for you.”

As the CEO of his health, Totoro’s supplement routine is customized. Magnesium is what introduced him to Thorne. And he’s excited about the development of leucine (found in SynaQuell, which supports cognition and focus) and Theanine (helps modify brain waves by increasing alpha-wave production. It also enhances brain neurotransmitters involved in stress management.)

Eric Dickerson Turns His Toughest Career Moments into Lessons for the Next Generation of Players

How College Athletic Departments Should Be Educating Their Athletes on NIL

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Humana's $2.8B BlackRock deal lets it buy back CenterWell clinics starting in 2028

Humana's $2.8B BlackRock deal lets it buy back CenterWell clinics starting in 2028

BlackRock's $2.8 billion buys majority ownership of a joint venture holding about 150 CenterWell clinics, replacing WCAS as Humana's outside investor. CenterWell keeps a minority stake and keeps running the clinics. The terms set a timeline: two years of expected growth spending, an option for Humana to buy clinics back from 2028, and a BlackRock right to start a sale of any clinics still in the venture at the end of 2033, with CenterWell getting the first offer. The deal is expected to close in the fourth quarter, subject to regulatory approvals.

  • 01BlackRock's $2.8 billion buys majority ownership of about 150 CenterWell clinics, while Humana keeps day-to-day management and an option to repurchase clinics starting in 2028.
  • 02The 2028 buyback and 2033 sale terms apply to the roughly 150 clinics in the new joint venture. CenterWell Senior Primary Care runs 250 clinics in total.
  • 03The deal’s lower-cost-of-capital claim will be tested after closing—first by how the venture deploys new capital over the next two years to support clinics, open locations and pursue acquisitions, and then by Humana’s 2028 decision on whether to start buying clinics back.

Nov 12, 2026

Healthcare AI should give doctors attention back, not shorter visits

Healthcare AI should give doctors attention back, not shorter visits

Healthcare organizations should deploy AI to give clinicians back attention and capacity for better decisions, not simply shorten visits. Landry argues AI should fit into existing workflows with insights appearing at the right time, and that organizations should set clear governance and automation boundaries before deployment and measure what changes for patients, clinicians and the organization.

  • 01AI success in healthcare should expand clinician capacity for thoughtful care, not optimize for visit speed; a three-minute appointment is not patient-centered innovation.
  • 02Design AI into workflows clinicians already use with insights appearing at the right moment, making adoption a workflow problem rather than a training problem.
  • 03Set automation boundaries before deploying AI, specifying what it may do alone, what it recommends for clinician decision-making, and what requires explicit human control and accountability.

Nov 11, 2026

Black Book: AI may make some outsourced health plan work cheaper to bring in-house

Black Book: AI may make some outsourced health plan work cheaper to bring in-house

U.S. health plan administrative costs rose 2.7% to about $69.2 billion in the first half of 2026, even as margins improved to 4.1%. Black Book Research's 2027 outlook says AI is starting to move payer sourcing in both directions. Demand for specialist vendors stays strong in some functions, while automation could make in-house or hybrid models viable in others. The report recommends comparing each major outsourced service with rival vendors and the best internal or hybrid option, and checking whether projected savings become actual cash.

  • 01Every major outsourced payer service should be benchmarked against a rival vendor and against the plan's best feasible internal or hybrid model, a three-way contest at each renewal.
  • 02Staffing reductions, payment recoveries, avoided vacancies and productivity improvements may not translate into recurring cash, so plans shouldn’t assume outsourcing savings can fund AI until the service, AI and funding cases are evaluated separately.
  • 03Provider data sits on both sides of the sourcing question: it is a top pain point and a specialist-demand area, yet also one of the functions where automation could make hybrid or in-house models viable.

Nov 11, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512